Kliničke studije za Меланом u državi Florida
56 studija za Меланом traži učesnike na lokacijama u državi Florida.
Gradovi u državi Florida
- Tampa21 студија
- Orlando17 студија
- Jacksonville16 студија
- Miami11 студија
- Hollywood5 студија
- Deltona5 студија
- St. Petersburg5 студија
- Lakeland5 студија
- Coral Springs5 студија
- Plantation4 студија
- Sarasota4 студија
- Deerfield Beach3 студија
- Cape Coral3 студија
Zvanični tekst studije (na engleskom)
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
- Mayo Clinic in Florida, Jacksonville
- AdventHealth Orlando, Orlando
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT05136196Adjuvant/Neoadjuvant Immunotherapy in Melanoma Based on Serial Plasma ctDNA Monitoring
- Moffitt Cancer Center, Tampa
Тражи се учесникФаза 2Здраве особе су добродошле
Узраст 18 и старији · Оба пола · Ажурирано 10. 11. 2026. · NCT07930182A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
- Mayo Clinic Florida, Jacksonville
- Boca Raton Clinical Research (BRCR) Global, Tamarac
- H. Lee Moffitt Cancer Center, Tampa
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 6. 11. 2026. · NCT06246916Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
- Clermont Oncology Center, Clermont
- Mid Florida Hematology and Oncology Center, Orange City
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 6. 11. 2026. · NCT04198766A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
- Florida Cancer Specialists - Lake Nona, Orlando
- Florida Cancer Specialists - Sarasota, Sarasota
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06150664Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Mount Sinai Comprehensive Cancer Center at Aventura, Aventura
- Schulze Family Foundation Cancer Clinic - Bonita Health Center, Bonita Springs
- Morton Plant Hospital, Clearwater
- и још 11
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст од 40 до 75 · Оба пола · Ажурирано 4. 11. 2026. · NCT05334069Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- Morton Plant Hospital, Clearwater
- South Florida Baptist Hospital, Plant City
- Saint Anthony's Hospital Cancer Care Center, St. Petersburg
- и још 2
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06418204SI-B036-ST-101 in Advanced/Metastatic Solid Tumors
- Florida Cancer Specialists Lake Nona, Orlando
- Florida Cancer Specialists Sarasota, Sarasota
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07857616Safety and Efficacy of OBX-115 in Advanced Solid Tumors
- University of Miami, Miami
- Advent Health Orlando, Orlando
- Orlando Health Cancer Institute (Melanoma/NSCLC), Orlando
- и још 1
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT06060613DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
- USA08-0, Florida City
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 29. 10. 2026. · NCT06953089A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- AdventHealth Medical Group Oncology Research at Celebration, Kissimmee
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 26. 10. 2026. · NCT06172478A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Research Site 118, Celebration
- Research Site 127, Margate
- Research Site 137, Orlando
- и још 2
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 21. 10. 2026. · NCT05914116Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer
- UM Sylvester Comprehensive Cancer Center at Aventura, Aventura
- UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables
- UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach
- и још 4
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 14. 10. 2026. · NCT05896839MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma
- Mayo Clinic, Jacksonville
- University of Miami, Miami
- Sarasota Memorial Hospital, Sarasota
Тражи се учесникФаза 1/2
Узраст од 18 до 90 · Оба пола · Ажурирано 13. 10. 2026. · NCT05655312A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
- Florida Cancer Specialists, Sarasota
- Moffitt Cancer Center, Tampa
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 9. 10. 2026. · NCT07070232Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program
- Mayo Clinic in Florida, Jacksonville
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 2. 10. 2026. · NCT06265285The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
- Mayo Clinic in Florida, Jacksonville
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 30. 9. 2026. · NCT07285044DESTINY-PANTUMOUR04
- Research Site, Coral Springs
- Research Site, St. Petersburg
- Research Site, West Palm Beach
Тражи се учесникОпсервациона студија
Узраст од 18 до 130 · Оба пола · Ажурирано 25. 9. 2026. · NCT07124000Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
- MDR Core Network, Boynton Beach
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 24. 9. 2026. · NCT06047379Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
- Orlando Health Cancer Institute, Orlando
Тражи се учесникФаза 3
Узраст од 18 до 70 · Оба пола · Ажурирано 24. 9. 2026. · NCT05727904Pan-tumor MRD Study
- Oncology & Hematology Associates of West Broward, Coral Springs
- Mid Florida Cancer Centers, Orange City
- Comprehensive Hematology Oncology (CHO), St. Petersburg
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 24. 9. 2026. · NCT06605404A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information
- Nemours Children's Clinic-Jacksonville, Jacksonville
- Nemours Children's Hospital, Orlando
- Nemours Children's Clinic - Pensacola, Pensacola
Тражи се учесникФаза 2
До 25 година · Оба пола · Ажурирано 24. 9. 2026. · NCT07621614Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
- Orlando Health Cancer Institute - Lake Mary, Lake Mary
- Lakeland Regional Health Hollis Cancer Center, Lakeland
- Health Central, Ocoee
- и још 1
Тражи се учесникФаза 3
Узраст 75 и старији · Оба пола · Ажурирано 24. 9. 2026. · NCT07068074Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease
- AdventHealth, Orlando
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 21. 9. 2026. · NCT06529822Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
- Sylvester Comprehensive Cancer Center - Miami, Miami
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 18. 9. 2026. · NCT05267626Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib Binimetinib in Melanoma
- Moffitt Cancer Center, Tampa
Тражи се учесникРана фаза 1
Узраст 18 и старији · Оба пола · Ажурирано 16. 9. 2026. · NCT04741997A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
- Orlando Health Cancer Institute, Orlando
- Moffitt Cancer Center-International Plaza, Tampa
- Moffitt Cancer Center - McKinley Campus, Tampa
- и још 1
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 15. 9. 2026. · NCT04511013ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Memorial Healthcare System, Hollywood
- The Oncology Institute of Hope & Innovation, Lakeland
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 14. 9. 2026. · NCT05059444A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
- Mayo Clinic - Florida, Jacksonville
- Sarah Cannon Research Institute - Florida Cancer Specialists, Orlando
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 2. 9. 2026. · NCT04913285Project: Every Child for Younger Patients With Cancer
- Broward Health Medical Center, Fort Lauderdale
- Golisano Children's Hospital of Southwest Florida, Fort Myers
- UF Health Cancer Institute - Gainesville, Gainesville
- и још 13
Тражи се учесникОпсервациона студија
До 25 година · Оба пола · Ажурирано 25. 8. 2026. · NCT02402244Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors
- Mayo Clinic in Florida, Jacksonville
Тражи се учесникФаза 1/2
Узраст 16 и старији · Оба пола · Ажурирано 20. 8. 2026. · NCT05269381A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- AdventHealth Celebration, Celebration
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 11. 8. 2026. · NCT05592626Nodal Radiation Therapy for Sentinel Lymph Node Positive Melanoma
- Baptist - MD Anderson Cancer Center, Jacksonville
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 10. 8. 2026. · NCT04594187The Florida ASCENT Study
- University of Florida, Gainesville
Тражи се учесник
Узраст од 18 до 100 · Оба пола · Ажурирано 23. 7. 2026. · NCT07042243Integrated Cancer Repository for Cancer Research
- Florida Hospital Memorial Medical Center, Daytona Beach
- Florida Hospital DeLand, DeLand
- Florida Hospital FISH, Orange City
- и још 2
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст од 19 до 110 · Оба пола · Ажурирано 29. 6. 2026. · NCT02012699Clinical Trial of CD40L-augmented TIL for Patients With Advanced Melanoma
- Moffitt Cancer Center, Tampa
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 26. 6. 2026. · NCT06961357MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors
- Moffitt Cancer Center, Tampa
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 11. 6. 2026. · NCT05076760A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
- Sylvester Comprehensive Cancer Center, Miami
- Orlando Health Cancer Institute, Orlando
- Moffitt Cancer Center, Tampa
Тражи се учесникФаза 1/2
Узраст од 18 до 70 · Оба пола · Ажурирано 11. 6. 2026. · NCT05361174Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
- Moffitt Cancer Center, Tampa
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 15. 5. 2026. · NCT05379985ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
- University of Miami Hospital and Clinics, Miami
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 13. 5. 2026. · NCT03686124Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.